301. Macular dystrophy
41 clinical trials,   47 drugs   (DrugBank: 12 drugs),   12 drug target genes,   66 drug target pathways

Searched query = "Macular dystrophy", "Best disease", "Stargardt disease", "Cone dystrophy", "Cone rod dystrophy", "X-linked juvenile retinoschisis", "Central areolar choroidal dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01278277
(ClinicalTrials.gov)
February 201114/1/2011Saffron Supplementation in Stargardt's DiseaseA Novel Therapeutic Strategy Targeting Photoreceptor Oxidative Damage in ABCR-related Retinal DegenerationsRetinal Degeneration;Genetic Disease;Single-Gene Defects;Macular DystrophyDietary Supplement: Saffron supplementation;Other: placeboCatholic University of the Sacred HeartNULLActive, not recruiting8 Years60 YearsAll30Phase 1;Phase 2Italy